Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Aug 14 2026 UPDATED 9:28 AM

Full Issue

Contrary To Expectations, Study Shows Cannabis Linked To Fewer Ectopic Heartbeats

While this new information may lead to new approaches for preventing or treating abnormal heart rhythms, experts caution that the overall health effects of inhaled cannabis may still be a net negative, MedPage Today reported.

MedPage Today: Researchers Try To Tie Cannabis To Irregular Heartbeats, Opposite Turns Out True

Defying expectations, regular cannabis users had fewer ectopic heartbeats on the days they reached for the joint or vape, a randomized crossover trial showed. (Lou, 8/13)

MedPage Today: Study Questions How Prostate Cancer Focal Therapy Is Being Used

While the use of focal therapy for nonmetastatic prostate cancer is limited, half of procedures occurred in settings that are not supported by current guidelines, according to a retrospective study. (Bassett, 8/13)

MedPage Today: JAK Inhibitor Might Be The Most Effective One Yet For Severe Alopecia

The JAK inhibitor upadacitinib (Rinvoq) dramatically improved hair regrowth for patients with severe alopecia areata in two parallel phase III trials, with results that appeared better than previously seen among the class of drugs. (Kneisel, 8/13)

MedPage Today: Preoperative GLP-1s Don't Diminish Bariatric Surgery Results, Study Suggests

Bariatric surgery patients who took GLP-1 medications prior to surgery lost the same amount of weight after 1 year as individuals unexposed to the blockbuster class of drugs, a retrospective review indicated. (Monaco, 8/13)

MedPage Today: Ozempic Teeth, Muscle Loss: Some Of The Buzziest GLP-1 Side Effects

GLP-1 drugs, used for type 2 diabetes and weight loss, have been touted for their many benefits, but it's their side effects that often make headlines, especially those with compelling monikers like "Ozempic teeth." (Fiore, 8/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, August 14
  • Thursday, August 13
  • Wednesday, August 12
  • Tuesday, August 11
  • Monday, August 10
  • Friday, August 7
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF